KATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response.
ATP-sensitive K+ (K(ATP)) channels maintain cardiac homeostasis under stress, as revealed by murine gene knockout models of the KCNJ11-encoded Kir6.2 pore. However, the translational significance of K(ATP) channels in human cardiac physiology remains largely unknown. Here, the frequency of the minor K23 allele of the common functional Kir6.2 E23K polymorphism was found overrepresented in 115 subjects with congestive heart failure compared to 2,031 community-based controls (69 vs. 56%, P < 0.001). Moreover, the KK genotype, present in 18% of heart failure patients, was associated with abnormal cardiopulmonary exercise stress testing. In spite of similar baseline heart rates at rest among genotypic subgroups (EE: 72.2 ± 2.3, EK: 75.0 ± 1.8 and KK:77.1 ± 3.0 bpm), subjects with the KK genotype had a significantly reduced heart rate increase at matched workload (EE: 32.8 ± 2.7%, EK: 28.8 ± 2.1%, KK: 21.7 ± 2.6%, P < 0.05), at 75% of maximum oxygen consumption (EE: 53.9 ± 3.9%, EK: 49.9 ± 3.1%, KK: 36.8 ± 5.3%, P < 0.05), and at peak V(O2) (EE: 82.8 ± 6.0%, EK: 80.5 ± 4.7%, KK: 59.7 ± 8.1%, P < 0.05). Molecular modeling of the tetrameric Kir6.2 pore structure revealed the E23 residue within the functionally relevant intracellular slide helix region. Substitution of the wild-type E residue with an oppositely charged, bulkier K residue would potentially result in a significant structural rearrangement and disrupted interactions with neighboring Kir6.2 subunits, providing a basis for altered high-fidelity K(ATP) channel gating, particularly in the homozygous state. Blunted heart rate response during exercise is a risk factor for mortality in patients with heart failure, establishing the clinical relevance of Kir6.2 E23K as a biomarker for impaired stress performance and underscoring the essential role of K(ATP) channels in human cardiac physiology.
Reyes
Santiago
S
Marriott Heart Disease Research Program, Mayo Clinic, Rochester, MN 55905, USA.
Park
Sungjo
S
Johnson
Bruce D
BD
Terzic
Andre
A
Olson
Timothy M
TM
D000328:Adult; D005080:Exercise Test; D005260:Female; D005838:Genotype; D006333:Heart Failure / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008958:Models, Molecular; D020641:Polymorphism, Single Nucleotide; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D017386:Sequence Homology, Amino Acid; D000099161:Kcnj11 Channel
D024661:Potassium Channels, Inwardly Rectifying; D000099161:Kcnj11 Channel
Hum Genet. 2005 Feb;116(3):133-45
15565284
Physiol Rev. 1998 Jan;78(1):227-45
9457174
Mol Cell Biochem. 2004 Jan-Feb;256-257(1-2):243-56
14977185
J Mol Cell Cardiol. 1999 Feb;31(2):425-34
10093054
Clin Pharmacol Ther. 2008 Feb;83(2):354-7
17957187
Eur Heart J. 2006 Mar;27(5):582-8
16399774
Science. 2003 Jun 20;300(5627):1922-6
12738871
Biochemistry. 2007 Mar 27;46(12):3643-52
17326663
J Mol Cell Cardiol. 2005 Jun;38(6):937-43
15910878
Hum Genet. 2008 Jul;123(6):665-7
18504616
J Clin Invest. 2005 Aug;115(8):2047-58
16075046
Am J Cardiol. 2000 Sep 15;86(6):602-9
10980208
Diabetes. 2005 May;54(5):1592-7
15855351
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7594-9
15126668
J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
2698218
J Appl Physiol (1985). 2007 Nov;103(5):1888-93
17641217
Cell. 2002 Dec 27;111(7):957-65
12507423
J Gen Physiol. 2008 Mar;131(3):185-96
18299394
J Mol Cell Cardiol. 2005 Jun;38(6):895-905
15910874
J Clin Invest. 2002 Feb;109(4):509-16
11854323
J Biol Chem. 2002 Jul 5;277(27):24427-34
11967264
N Engl J Med. 2005 May 12;352(19):1951-8
15888695
Nat Genet. 2004 Apr;36(4):382-7
15034580
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1706-13
17189350
Nature. 2006 Mar 23;440(7083):470-6
16554807
Curr Opin Struct Biol. 2008 Jun;18(3):342-8
18436442
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13278-83
12271142
Diabetes. 2004 Dec;53 Suppl 3:S165-8
15561906
J Physiol. 2005 Jan 1;562(Pt 1):223-34
15498808
J Appl Physiol (1985). 2005 Nov;99(5):1776-81
15994241
Diabetes. 2003 Oct;52(10):2630-5
14514649
J Physiol. 2006 Dec 15;577(Pt 3):1053-65
17038430
J Physiol. 1996 Jan 15;490 ( Pt 2):337-50
8821133
Hum Mol Genet. 2006 Aug 1;15(15):2285-97
16782803
N Engl J Med. 2009 Apr 23;360(17):1696-8
19369660
Nature. 2006 Mar 23;440(7083):440-7
16554803
Diabetes. 2009 Aug;58(8):1869-78
19491206
J Proteome Res. 2008 Apr;7(4):1721-8
18311911
Proteomics. 2009 Mar;9(5):1314-25
19253285
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7623-8
11390963
Proteins. 1992 Apr;12(4):345-64
1579569
EMBO J. 2003 Apr 15;22(8):1732-42
12682006
Stem Cells. 2008 Oct;26(10):2644-53
18669912
J Physiol. 2008 Jun 1;586(11):2767-78
18420708
Circulation. 1989 Aug;80(2):314-23
2546698
J Am Coll Cardiol. 2003 Sep 3;42(5):823-30
12957427
Mol Psychiatry. 2007 Dec;12(12):1060-1
18043710
Mol Psychiatry. 2003 Mar;8(3):253-4
12660794
J Am Soc Echocardiogr. 2007 Mar;20(3):290-7
17336757
Diabetes. 2004 Dec;53 Suppl 3:S169-75
15561907
J Am Coll Cardiol. 2006 Sep 19;48(6):1250-6
16979014
J Mol Cell Cardiol. 2005 Jun;38(6):917-25
15910876
EMBO J. 2005 Jan 26;24(2):229-39
15650751
Exp Physiol. 2008 Jan;93(1):95-103
17720745
J Appl Physiol (1985). 2004 Jul;97(1):72-6
14990555
Am Heart J. 2008 Dec;156(6):1177-83
19033016
Chest. 2006 Nov;130(5):1527-34
17099033
Diabetes. 2002 Mar;51(3):875-9
11872696
Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):110-6
17245405
FASEB J. 2006 Nov;20(13):2271-80
17077304
Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2106-13
12598229
Science. 1995 Nov 17;270(5239):1166-70
7502040
BMC Biol. 2007 May 08;5:17
17488521